Susceptibility to β-amyloid-induced toxicity is decreased in Goto- Kakizaki diabetic rats: Involvement of oxidative stress

Experimental Neurology

Volumn 161, Issue 1, 2000, Pages 383-391

  Pereira, Cláudia ^a   Moreira, Paula ^a   Seiça, Raquel ^a   Santos, Maria Sancha ^a   Oliveira, Catarina R ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Alzheimer's disease; Antioxidants; Diabetes; Hyperglycaemia; Oxidative stress; Synaptosomes; amyloid peptide

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN METABOLISM; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HYPERGLYCEMIA; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 0034051172     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7270     Document Type: Article

References (56)

1. Behl C., Davis J., Cole G. M., Schubert D. Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem. Biophys. Res. Commun. 186:1992;944-950.
2. Behl C., Davis J. B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
3. Biessels G. J., Kappelle A. C., Bravenboer B., Erkelens D. W., Gispen W. H. Cerebral function in diabetes mellitus. Diabetologia. 37:1994;643-650.
4. Blum-Degen D., Frölich L., Hoyer S., Riederer P. Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders. J. Neural Transm. (Suppl.). 46:1995;139-147.
5. Brownlee M., Vlassara H., Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann. Intern. Med. 101:1984;527-537.
6. Bruce A. J., Malfroy B., Baudry M. β-amyloid toxicity in organotypic cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc. Natl. Acad. Sci. USA. 88:1996;3633-3636.
7. Burton G. W., Webb A., Ingold K. V. A mild, rapid and efficient method of lipid extraction for use in determining vitamin E/lipid ratios. Lipids. 20:1985;29-39.
8. Butterfield D. A., Hensley K., Harris M., Mattson M. P., Carney J. β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200:1994;710-715.
9. Coyle J. T., Price D. L., DeLong M. R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 219:1983;1184-1190.
10. Duhault J., Koenig-Berard E. Le diabète et ses modèles animaux. Thérapie. 52:1997;375-384.
11. Dyrks L. L., Dyrks E., Hartmann T., Masters C., Beyreuther K. E. Amyloidogenicity of βA4 and βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267:1992;18210-18217.
12. Finch C. E., Cohen D. M. Aging, metabolism and Alzheimer's disease: review and hypotheses. Exp. Neurol. 143:1997;82-102.
13. Fu M. X., Wells Knecht K. J., Blackledje J. A., Lyons T. J., Thorpe S. R., Baynes J. W. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes. 43:1994;676-683.
14. Goto Y., Kakizaki M., Masaki N. Spontaneous diabetes produced by selective breeding of normal Wistar rats. Proc. Natl. Jpn. Acad. 51:1975;80-85.
15. Goto Y., Kakizaki M. The spontaneous-diabetes rat: a model of noninsulin dependent diabetes mellitus. Proc. Natl. Jpn. Acad. 57:1981;381-384.
16. Goto Y., Susuki K., Ono T., Sasaki M., Toyota T. Development of diabetes in non-obese NIDDM rat (GK rat). Adv. Exp. Med. Biol. 246:1988;29-31.
17. Greene D. A., Lattimer S. A., Sima A. A. F. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N. Engl. J. Med. 316:1987;599-606.
18. Griesmacher A., Kindhauser M., Andert S. E. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am. J. Med. 98:1995;469-475.
19. Hajós F. An improved method for the preparation of synaptosomal fractions in high purity. Brain Res. 93:1975;485-489.
20. Harris M. E., Hensley K., Butterfield D. A., Leedle R. E., Carney J. M. Direct evidence of oxidative injury by the Alzheimer's amyloid β peptide in cultured hippocampal neurons. Exp. Neurol. 131:1995;193-202.
21. Henneberg N., Hoyer S. Desensitization of the neuronal insulin receptor: A new approach in the etiopathogenesis of late-onset sporadic dementia of the Alzheimer type (SDAT). Arch. Geront. Geriat. 21:1995;63-74.
22. Hensley K., Butterfield D. A., Hall N., Cole P., Subramaniam R., Mark R., Mattson M. P., Markesbery W. R., Harris M. E., Aksenov M., Aksenova M., Wu J. F., Carney J. M. Oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated amyloid beta peptide. Ann. N. Y. Acad. Sci. 786:1996;120-134.
23. Hoyer S. Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease. Acta Neurol. Scand. (Suppl.). 165:1996;18-24.
24. Hoyer S. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J. Neural Transm. 105:1998;415-422.
25. Kang J., Lemaire H.-G., Unterbeck A., Salbaum J. M., Masters S. L., Grzesckik K.-H., Multhaup G., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature. 325:1987;733-736.
26. Kauppinen R. A., Nicholls D. G. Synaptosomal bioenergetics: The role of glycolysis, pyruvate oxidation and responses to hypoglycemia. Eur. J. Biochem. 158:1986;159-165.
27. Keller J. N., Pang Z., Geddes J. W., Begley J. G., Germeyer A., Waeg G., Mattson M. P. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: Role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69:1997a;273-284.
28. Keller J. N., Mark R. J., Bruce A. J., Blanc E., Rothstein J. D., Uchida K., Waeg K., Mattson M. P. 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience. 80:1997b;685-696.
29. Kumar J. S., Menon V. P. Peroxidative changes in experimental diabetes mellitus. Ind. J. Med. Res. 96:1992;176-181.
30. Layne E. Spectrophotometric and turbidimetric methods for measuring proteins. Methods Enzymol. 3:1957;447-451.
31. Leenheer A. P. D., Bevere V. O. R. C. D., Claeys A. E. Measurement of α, β, γ-tocopherol in serum by liquid chromatography. Clin. Chem. 25:1979;425-428.
32. Levine R. L., Garland D., Oliver C. N., Amici A., Climent I., Lenz A. G., Ahn B. W., Shaltiel S., Stadtman E. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186:1990;464-478.
33. McCall A. L. The impact of diabetes on the CNS. Diabetes. 41:1992;557-570.
34. Messier C., Gagnon M. Glucose regulation and cognitive functions: Relation to Alzheimer's disease and diabetes. Behav. Brain Res. 75:1996;1-11.
35. Mooradian A. D. Diabetes and the Central Nervous System. Endocr. Rev. 9:1988;346-356.
36. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
37. Mukherjee B., Mukherjee J. R., Chatterjee M. Lipid peroxidation, glutathione levels and changes in glutathione-related enzyme activities in streptozotocin-induced diabetic rats. Immunol. Cell Biol. 72:1994;109-114.
38. Ott A., Stolk R. P., Hofman A., van Harskamp F., Grobbee D. E., Breteler M. M. B. Association of diabetes mellitus and dementia: the Roterdam study. Diabetologia. 39:1996;1392-1397.
39. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., Cotman C. W. Neurodegeneration induced by β-amyloid peptides in vitro: The role of protein assembly state. J. Neurosci. 13:1993;1676-1687.
40. Schubert D., Behl C., Lesley R., Brack A., Dargusch R., Sagara Y., Kimura H. Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl. Acad. Sci. USA. 92:1995;1989-1993.
41. Serradas P., Gangnerau M.-N., Giroix M.-H., Saulnier C., Borg L. A. H., Portha B. Impaired pancreatic β cell function in the fetal GK rat. J. Clin. Invest. 101:1998;899-904.
42. Skoog I. Risk factors for vascular dementia: A review. Dementia. 5:1994;137-144.
43. Smith M. A., Sayre L. M., Vitek M. P., Monnier V. M., Perry G. Early AGEing and Alzheimer's. Nature. 374:1995;316.
44. Smith M. A., Sayre L. M., Perry G. Diabetes mellitus and Alzheimer's disease: Glycation as a biochemical link. Diabetologia. 39:1996;247.
45. Smyth M. D., Kesslak J. P., Cummings B. J., Cotman C. W. Analysis of brain injury following intrahippocampal administration of beta-amyloid in streptozotocin-treated rats. Neurobiol. Aging. 15:1994;153-159.
46. Stocchi V., Cucchiarini L., Chiarantini L., Palma P., Crescentini G. Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells. Anal. Biochem. 146:1985;118-124.
47. Strowing S., Raskin P. Glycemic control and diabetic complications. Diabetes Care. 15:1992;1126-1140.
48. Sukalski K. A., Pinto K. A., Berntson J. L. Decreased susceptibility of liver mitochondria from diabetic rats to oxidative damage and associated increase in α-tocopherol. Free Rad. Biol. Med. 14:1993;57-65.
49. Umbauer S. A., Isbell B. I., Butterfield D. A. Spin labeling of membrane proteins in mammalian brain synaptic plasma membranes: Partial characterization. Anal. Lett. 25:1992;1201-1215.
50. Van Dam P. S., Van Asbeck B. S., Erkelens D. W., Marx J. J. M., Gispen W. H., Bravenboer B. The role of oxidative stress in neuropathy and other diabetic complications. Diabetes Metab. Res. 11:1995;181-192.
51. Van Dam P. S., Bravenboer B., Van Asbeck B. S., Van Oirschot J. F. L. M., Marx J. J. M., Gispen W. H. Effects of insulin treatment on endoneurial and systemic oxidative stress in relation to nerve conduction in streptozotocin-diabetic rats. Eur. J. Clin. Invest. 26:1996;1143-1149.
52. Vatassery G. T., Maynard U. R., Hagen D. F. High-performance liquid chromatography of various tocopherols. J. Chromatogr. 161:1978;299-302.
53. Zafra F., Aragón C., Giménez C. Molecular biology of glycinergic neurotransmission. Mol. Neurobiol. 14:1997;117-142.
54. Wills E. D. Lipid peroxide formation in microsomes. General considerations. Biochem. J. 113:1969;315-324.
55. Wolff S. P., Jiang Z. Y., Hunt J. V. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Rad. Biol. Med. 10:1991;339-352.
56. Yankner B. A. Mechanisms of neuronal degeneration in Alzheimer's disease. Nature. 382:1996;685-691.